← All companies

LPCN

Lipocine Inc.

LPCN Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.13

+0.02 +0.95%

Key statistics

from XBRL data in SEC filings

Market cap

$17.6M

Revenue (TTM)

$1.57M

Net income (TTM)

-$11.9M

EPS (TTM)

$-1.79

P/E ratio

—

Dividend yield

—

Free cash flow

-$9.85M

Cash

$4.98M

Total assets

$23.8M

Gross margin

—

52-week range

$1.81 – $12.37

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Aug 4, 2026 10-Q Quarter ended 2026-06-30 Aug 4, 2026 8-K Director or officer change; Regulation FD disclosure Aug 3, 2026 8-K Other events Jun 12, 2026 8-K Director or officer change; Shareholder vote results Jun 4, 2026 8-K Other events Jun 4, 2026 8-K Other events May 26, 2026 8-K Other events May 19, 2026 8-K Other events May 18, 2026 8-K Other events May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change Apr 21, 2026 8-K Other events Apr 2, 2026 8-K Other events Apr 2, 2026 8-K Results of operations (earnings release) Mar 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Other events Mar 4, 2026 8-K Other events Feb 18, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Feb 18, 2026 8-K Other events Jan 20, 2026 8-K Other events Jan 12, 2026 8-K Other events Jan 12, 2026 8-K Other events Dec 16, 2025 8-K Director or officer change Dec 15, 2025 8-K Other events Dec 11, 2025 8-K Other events Nov 18, 2025 8-K Other events Nov 18, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Other events Nov 4, 2025 8-K Other events Sep 30, 2025 8-K Other events Sep 26, 2025 8-K Other events Sep 5, 2025 8-K Other events Sep 5, 2025 8-K Other events Aug 26, 2025 8-K Results of operations (earnings release) Aug 5, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Other events Jul 9, 2025 8-K Other events Jul 2, 2025